Source: Virtual Congress 2021 – COVID - 19 treatments



Rating:

Share or cite this content

Citations should be made in the following way:
P. Sivapalan (Hellerup, Roskilde, Denmark), C. Ulrik (Hvidovre, Denmark), T. Lapperre (Copenhagen, Denmark), R. Bojesen (Slagelse, Denmark), J. Eklöf (Hellerup, Denmark), A. Browatzki (Hillerød, Denmark), J. Wilcke (Hellerup, Denmark), V. Gottlieb (Hellerup, Denmark), K. Håkonsson (Hvidovre, Denmark), C. Tidemandsen (Hvidovre, Denmark), O. Tupper (Hvidovre, Denmark), H. Meteran (Hellerup, Denmark), C. Bergsøe (Hellerup, Denmark), E. Brøndum (Hvidovre, Denmark), U. Bødtger (1) Roskilde 2) Slagelse 3) Odense, Denmark), D. Rasmussen (Slagelse, Denmark), S. Jensen (Hellerup, Denmark), L. Pedersen (Copenhagen, Denmark), A. Jordan (Hellerup, Denmark), H. Priemé (Hellerup, Denmark), C. Søborg (Herlev, Denmark), I. Steffensen (Herlev , Denmark), D. Høgsberg (Hellerup, Denmark), T. Klausen (Herlev, Denmark), M. Frydland (Roskilde, Denmark), P. Lange (Hellerup, Denmark), A. Sverrild (Copenhagen, Denmark), M. Ghanizada (Copenhagen, Denmark), F. Knop (Hellerup, Denmark), T. Biering-Sørensen (Hellerup, Denmark), J. Lundgren (Copenhagen, Denmark), J. Jensen (Hellerup, Denmark). Azithromycin and Hydroxychloroquine in hospitalized patients with confirmed SARS-CoV-2 infection - a randomized placebo-controlled trial (ProPAC-COVID Trial). 3668

Member's Comments

No comment yet.

Related content which might interest you: Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO) Source: ERJ Open Res, 8 (1) 00610-2021; 10.1183/23120541.00610-2021 Year: 2022 Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial Source: Eur Respir J, 59 (1) 2100752; 10.1183/13993003.00752-2021 Year: 2022 Roflumilast in Asian patients with COPD: A randomised placebo-controlled trial Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial Source: Eur Respir J, 58 (4) 2002819; 10.1183/13993003.02819-2020 Year: 2021 Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial Source: Eur Respir J, 59 (2) 2101471; 10.1183/13993003.01471-2021 Year: 2022 Methotrexate in treatment of severe difficult-to-treat asthma: randomized, double-blind, placebo-controlled study Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007 PRAISE, a randomized, placebo-controlled, double-blind Phase 2 clinical trial of pamrevlumab (FG-3019) in IPF patients Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights Year: 2017 RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations Source: Virtual Congress 2021 – ALERT: COPD Year: 2021 Antibiotic in non-purulent hospitalised-treated exacerbations of COPD: a randomised double-blind placebo-controlled trial Source: International Congress 2019 – Airway infection in COPD Year: 2019 Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 Umeclidinium in patients with COPD: a randomised, placebo-controlled study Source: Eur Respir J 2014; 43: 72-81 Year: 2004 RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021 A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis Source: Eur Respir J 2014; 43: 1114-1123 Year: 2014 Efficacy of azithromycin in severe asthma from the AMAZES randomised trial Source: ERJ Open Res, 5 (4) 00056-2019; 10.1183/23120541.00056-2019 Year: 2019 Recombinant human deoxyribonuclease (rhDNase) for the treatment of acute asthma in children: a multicentre randomised double-blind clinical trial Source: Annual Congress 2007 - Childhood asthma: treatment and follow-up Year: 2007 Randomised, double-blind, placebo-controlled trial of EPS® 7630 in adults with COPD Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009 Tiotropium treatment for bronchiectasis (ROBUST): a randomized, placebo-controlled, crossover trial Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 Effects of a concomitant therapy with Cineole (Eucalyptole) on exacerbation rate in COPD: A placebo-controlled double-blind trial Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021 Year: 2021